Ausgabe 1/2013
Inhalt (27 Artikel)
The 50th Annual Meeting of the International Association of Forensic Toxicologists
Osamu Suzuki
Simultaneous determination of amphetamine-type stimulants in abusers’ hair: clinical usefulness of hair analysis in prehospitalization for abusers
Mitsuhiro Wada, Yuki Sugimoto, Brian L. Crabtree, Cynthia Evans, John H. Montgomery, Rie Ikeda, Naotaka Kuroda, Kenichiro Nakashima
High-throughput determination of barbiturates in human plasma using on-line column-switching ultra-fast liquid chromatography–tandem mass spectrometry
Xiao-Pen Lee, Takeshi Kumazawa, Chika Hasegawa, Tetsuya Arinobu, Hiroshi Seno, Osamu Suzuki, Keizo Sato
Analysis of the prevalence and coexistence of synthetic cannabinoids in “herbal high” products in Poland
Dariusz Zuba, Bogumiła Byrska
Hollow fiber–liquid phase microextraction of barbiturates in liver samples
Rafael Almeida Menck, Carolina Dizioli Rodrigues de Oliveira, Diógenes Saulo de Lima, Ligia Endo Goes, Vilma Leyton, Carlos Augusto Pasqualucci, Daniel Romero Muñoz, Mauricio Yonamine
Decontamination of nerve agents by immobilized organophosphorus hydrolase
Takeshi Ohmori, Kazuyoshi Kawahara, Kosuke Nakayama, Aki Shioda, Satoshi Ishikawa, Mieko Kanamori-Kataoka, Shintaro Kishi, Asuka Komano, Yasuo Seto
Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012
Ruri Kikura-Hanajiri, Nahoko Uchiyama, Maiko Kawamura, Yukihiro Goda
Identification of N-ethyl-α-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug?
Jaesin Lee, Sanggil Choe, Hyeyoung Choi, Sewoong Heo, Eunmi Kim, Hyunju Kim, Eunjung Bang, Heesun Chung
Formation of semi-crystalline fraction, in which all diethylene glycol (DEG) is contained, during its extraction from human tissues: the probable cause of false negative results in fatal DEG poisoning cases
Leda Giannuzzi, Luis A. Ferrari
Single-chain variable fragment technology in forensic toxicological analysis: production of an antibody to fluvoxamine
Ako Sasao, Yoshiaki Suwa, Taemi Aso, Hiroe Kohmatsu, Yuki Ohtsu, Satoko Mishima, Kosei Yonemitsu, Hiroshi Morioka, Yoko Nishitani
Combination of a short middle-bore capillary column with a thicker stationary phase and a short narrow-bore separation column with a thinner stationary phase for the rapid screening of non-volatile drugs by gas chromatography–mass spectrometry
Brian Waters, Kenji Hara, Masayuki Kashiwagi, Aya Matsusue, Tomoko Sugimura, Saiko Hamasato, Shin-ichi Kubo
Significance of CYP2C9 genetic polymorphism in inhibitory effect of Δ9-tetrahydrocannabinol on CYP2C9 activity
Satoshi Yamaori, Mika Kushihara, Kyoko Koeda, Ikuo Yamamoto, Kazuhito Watanabe
Analysis of azepane isomers of AM-2233 and AM-1220, and detection of an inhibitor of fatty acid amide hydrolase [3′-(aminocarbonyl)(1,1′-biphenyl)-3-yl]-cyclohexylcarbamate (URB597) obtained as designer drugs in the Tokyo area
Jun’ichi Nakajima, Misako Takahashi, Takako Seto, Chieko Kanai, Jin Suzuki, Masao Yoshida, Nozomi Uemura, Tomoko Hamano
Identification of (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone and its 5-pentyl fluorinated analog in herbal incense seized for drug trafficking
Hyeyoung Choi, Sewoong Heo, Eunmi Kim, Bang Yeon Hwang, Chul Lee, Jaesin Lee
New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products
Nahoko Uchiyama, Satoru Matsuda, Daigo Wakana, Ruri Kikura-Hanajiri, Yukihiro Goda
Urinary excretion and metabolism of the newly encountered designer drug 3,4-dimethylmethcathinone in humans
N. Shima, M. Katagi, H. Kamata, S. Matsuta, K. Nakanishi, K. Zaitsu, T. Kamata, H. Nishioka, A. Miki, M. Tatsuno, T. Sato, H. Tsuchihashi, K. Suzuki
Real-time near-body drug screening during autopsy I: use of the Randox biochip drugs of abuse DOA I and DOA II immunoassays
Poppy McLaughlin, Derrick Pounder, Peter Maskell, David Osselton
Simple and rapid determination of myristicin in human serum
Andrzej L. Dawidowicz, Michal P. Dybowski
Simultaneous determination of new-generation antidepressants in plasma by gas chromatography–mass spectrometry
Elisa Pietracci, Ana-María Bermejo, Iván Álvarez, Pamela Cabarcos, Walter Balduini, María-Jesús Tabernero
Cross-reactivities of 41 new amphetamine designer drugs to EMIT® immunoassays
Maria Nieddu, Claudia Trignano, Lucia Burrai, Maria Antonietta Pirisi, Gianpiero Boatto
MALDI-TOF mass spectrometric determination of 11 phenothiazines with heavy side chains in urine
Kayoko Minakata, Itaru Yamagishi, Hideki Nozawa, Kunio Gonmori, Koutaro Hasegawa, Amin Wurita, Masako Suzuki, Kanako Watanabe, Osamu Suzuki
Identification and quantitation of JWH-213, a cannabimimetic indole, as a designer drug in a herbal product
Kazunaga Takahashi, Nahoko Uchiyama, Tomohide Fukiwake, Takashi Hasegawa, Masaaki Saijou, Yuji Motoki, Ruri Kikura-Hanajiri, Yukihiro Goda
Analysis of cannabinoids in oral fluid by liquid chromatography–tandem mass spectrometry
Marie Fabritius, Christian Staub, Patrice Mangin, Christian Giroud
Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201
Adrian Derungs, Andrea E. Schwaninger, Gregory Mansella, Roland Bingisser, Thomas Kraemer, Matthias E. Liechti
Pathological and toxicological findings in four cases of fatal hydrogen sulfide inhalation
Takako Miyazato, Takaki Ishikawa, Tomomi Michiue, Shigeki Oritani, Hitoshi Maeda
A case of drowning lacking typical autopsy findings of carbon monoxide poisoning despite the high CO concentration
Junko Fujihara, Masanori Hasegawa, Takao Kato, Masakazu Miura, Kumiko Iida, Hiroshi Kinoshita, Naoko Tanaka, Haruo Takeshita
Application of high-throughput chiral analysis of amphetamines by GC–MS to whole blood specimens
Hiroshi Fujii, Kenji Hara, Masayuki Kashiwagi, Aya Matsusue, Brian Waters, Shin-ichi Kubo